Bianco, A.; Di Sante, G.; Colò, F.; De Arcangelis, V.; Cicia, A.; Del Giacomo, P.; De Bonis, M.; Morganti, T.G.; Carlomagno, V.; Lucchini, M.;
et al. Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? Int. J. Mol. Sci. 2024, 25, 4556.
https://doi.org/10.3390/ijms25084556
AMA Style
Bianco A, Di Sante G, Colò F, De Arcangelis V, Cicia A, Del Giacomo P, De Bonis M, Morganti TG, Carlomagno V, Lucchini M,
et al. Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? International Journal of Molecular Sciences. 2024; 25(8):4556.
https://doi.org/10.3390/ijms25084556
Chicago/Turabian Style
Bianco, Assunta, Gabriele Di Sante, Francesca Colò, Valeria De Arcangelis, Alessandra Cicia, Paola Del Giacomo, Maria De Bonis, Tommaso Giuseppe Morganti, Vincenzo Carlomagno, Matteo Lucchini,
and et al. 2024. "Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?" International Journal of Molecular Sciences 25, no. 8: 4556.
https://doi.org/10.3390/ijms25084556
APA Style
Bianco, A., Di Sante, G., Colò, F., De Arcangelis, V., Cicia, A., Del Giacomo, P., De Bonis, M., Morganti, T. G., Carlomagno, V., Lucchini, M., Minucci, A., Calabresi, P., & Mirabella, M.
(2024). Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? International Journal of Molecular Sciences, 25(8), 4556.
https://doi.org/10.3390/ijms25084556